Literature DB >> 9678704

Mutation analysis of the nerve specific promoter of the peripheral myelin protein 22 gene in CMT1 disease and HNPP.

E Nelis1, P De Jonghe, E De Vriendt, P I Patel, J J Martin, C Van Broeckhoven.   

Abstract

We analysed the nerve specific promoter of the peripheral myelin protein 22 gene (PMP22) in a set of 15 unrelated patients with Charcot-Marie-Tooth type 1 disease (CMT1) and 16 unrelated patients with hereditary neuropathy with liability to pressure palsies (HNPP). In these patients no duplication/deletion nor a mutation in the coding region of the CMT1/ HNPP genes was detected. In one autosomal dominant CMT1 patient, we identified a base change in the non-coding exon 1A of PMP22 which, however, did not cosegregate with the disease in the family. This study indicates that mutations in the nerve specific PMP22 promoter and 5' untranslated exon will not be a common genetic cause of CMT1A and HNPP.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9678704      PMCID: PMC1051370          DOI: 10.1136/jmg.35.7.590

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  13 in total

1.  Mutations of the noncoding region of the connexin32 gene in X-linked dominant Charcot-Marie-Tooth neuropathy.

Authors:  V V Ionasescu; C Searby; R Ionasescu; I M Neuhaus; R Werner
Journal:  Neurology       Date:  1996-08       Impact factor: 9.910

2.  Comparison of single-strand conformation polymorphism and heteroduplex analysis for detection of mutations in Charcot-Marie-Tooth type 1 disease and related peripheral neuropathies.

Authors:  E Nelis; L E Warner; E D Vriendt; P F Chance; J R Lupski; C Van Broeckhoven
Journal:  Eur J Hum Genet       Date:  1996       Impact factor: 4.246

3.  DNA duplication associated with Charcot-Marie-Tooth disease type 1A.

Authors:  J R Lupski; R M de Oca-Luna; S Slaugenhaupt; L Pentao; V Guzzetta; B J Trask; O Saucedo-Cardenas; D F Barker; J M Killian; C A Garcia; A Chakravarti; P I Patel
Journal:  Cell       Date:  1991-07-26       Impact factor: 41.582

4.  Estimation of the size of the chromosome 17p11.2 duplication in Charcot-Marie-Tooth neuropathy type 1a (CMT1a). HMSN Collaborative Research Group.

Authors:  P Raeymaekers; V Timmerman; E Nelis; W Van Hul; P De Jonghe; J J Martin; C Van Broeckhoven
Journal:  J Med Genet       Date:  1992-01       Impact factor: 6.318

Review 5.  Charcot-Marie-Tooth disease and related peripheral neuropathies.

Authors:  P De Jonghe; V Timmerman; E Nelis; J J Martin; C Van Broeckhoven
Journal:  J Peripher Nerv Syst       Date:  1997       Impact factor: 3.494

6.  Mutation analysis of the connexin 32 (Cx32) gene in Charcot-Marie-Tooth neuropathy type 1: identification of five new mutations.

Authors:  E Nelis; S Simokovic; V Timmerman; A Löfgren; H Backhovens; P De Jonghe; J J Martin; C Van Broeckhoven
Journal:  Hum Mutat       Date:  1997       Impact factor: 4.878

7.  Regulation of tissue-specific expression of alternative peripheral myelin protein-22 (PMP22) gene transcripts by two promoters.

Authors:  U Suter; G J Snipes; R Schoener-Scott; A A Welcher; S Pareek; J R Lupski; R A Murphy; E M Shooter; P I Patel
Journal:  J Biol Chem       Date:  1994-10-14       Impact factor: 5.157

8.  The peripheral myelin protein gene PMP-22 is contained within the Charcot-Marie-Tooth disease type 1A duplication.

Authors:  V Timmerman; E Nelis; W Van Hul; B W Nieuwenhuijsen; K L Chen; S Wang; K Ben Othman; B Cullen; R J Leach; C O Hanemann
Journal:  Nat Genet       Date:  1992-06       Impact factor: 38.330

9.  Prenatal diagnosis of Charcot-Marie-Tooth disease type 1A (CMT1A) using molecular genetic techniques.

Authors:  R Navon; V Timmerman; A Löfgren; P Liang; E Nelis; M Zeitune; C Van Broeckhoven
Journal:  Prenat Diagn       Date:  1995-07       Impact factor: 3.050

10.  Charcot-Marie-Tooth disease type 1A. Association with a spontaneous point mutation in the PMP22 gene.

Authors:  B B Roa; C A Garcia; U Suter; D A Kulpa; C A Wise; J Mueller; A A Welcher; G J Snipes; E M Shooter; P I Patel; J R Lupski
Journal:  N Engl J Med       Date:  1993-07-08       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.